Antibiotic resistance: where are we going?

被引:14
作者
La Fauci, V [1 ]
Alessi, V [2 ]
机构
[1] Univ Messina, Dept Biomed & Dent Sci & Morphofunct Imaging, AOU Policlin G Martino, Biol Tour 1 Floor,Via Consolare Valeria, I-98125 Messina, Italy
[2] Univ Messina, Postgrad Med Sch Hyg & Prevent Med, Messina, Italy
来源
ANNALI DI IGIENE MEDICINA PREVENTIVA E DI COMUNITA | 2018年 / 30卷 / 04期
关键词
Antibiotic resistance; MDRO; carbapenem-resistant; ESBL;
D O I
10.7416/ai.2018.2235
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Antibiotic resistance represents the greatest threat in the field of infectious diseases today, due to the sharp increase of this event both in Europe and the World. The presence of these multidrug-resistant microorganisms in hospitals is associated with many risks, including the increased likelihood of treatment failure, an increased risk of morbidity and mortality, longer hospital stay, higher hospitalization costs and more legal disputes. The epidemiology of multidrug-resistant microorganisms infections varies from year to year, by geographical area, by hospital and by ward or department. Italy lies in fifth place among European countries regarding the use of antibiotics in human and veterinary clinical practice. Unfortunately, antibiotic resistance remains one of the highest in Europe and is consistently above the European average for both Gram negative and positive bacteria. The appearance and the growth of resistance to Carbapenems has been rapid, alarming and dramatic in Italy so much that the country is now classified as hyperendemic. It is important to highlight the known and emerging risk factors to define multidrug-resistant microorganisms prevention and control measures, both at individual and community level.
引用
收藏
页码:52 / 57
页数:6
相关论文
共 18 条
  • [1] [Anonymous], 2016, TACKLING DRUG RESIST
  • [2] ECDC, 2017, SURV ANT RES EUR 201
  • [3] Occurrence of carbapenemase-producing Klebsiella pneumoniae and Escherichia coli in the European survey of carbapenemase-producing Enterobacteriaceae (EuSCAPE): a prospective, multinational study
    Grundmann, Hajo
    Glasner, Corinna
    Albiger, Barbara
    Aanensen, David M.
    Tomlinson, Chris T.
    Tambic Andrasevic, Arjana
    Canton, Rafael
    Carmeli, Yehuda
    Friedrich, Alexander W.
    Giske, Christian G.
    Glupczynski, Youri
    Gniadkowski, Marek
    Livermore, David M.
    Nordmann, Patrice
    Poirel, Laurent
    Rossolini, Gian M.
    Seifert, Harald
    Vatopoulos, Alkiviadis
    Walsh, Timothy
    Woodford, Neil
    Monnet, Dominique L.
    Apfalter, Petra
    Hartl, Rainer
    Glupczynski, Youri
    Huang, Te-Din
    Strateva, Tanya
    Marteva-Proevska, Yuliya
    Andrasevic, Arjana Tambic
    Butic, Iva
    Pieridou-Bagatzouni, Despo
    Maikanti-Charalampous, Panagiota
    Hrabak, Jaroslav
    Zemlickova, Helena
    Hammerum, Anette
    Jakobsen, Lotte
    Ivanova, Marina
    Pavelkovich, Anastasia
    Jalava, Jari
    Osterblad, Monica
    Vaux, Sophie
    Dortet, Laurent
    Kaase, Martin
    Gatermann, Soeren G.
    Vatopoulos, Alkiviadis
    Tryfinopoulou, Kyriaki
    Toth, Akos
    Janvari, Laura
    Boo, Teck Wee
    McGrath, Elaine
    Pantosti, Annalisa
    [J]. LANCET INFECTIOUS DISEASES, 2017, 17 (02) : 153 - 163
  • [4] Attributable mortality of carbapenem-resistant Klebsiella pneumoniae infections in a prospective matched cohort study in Italy, 2012-2013
    Hoxha, A.
    Kaerki, T.
    Giambi, C.
    Montano, C.
    Sisto, A.
    Bella, A.
    D'Ancona, F.
    [J]. JOURNAL OF HOSPITAL INFECTION, 2016, 92 (01) : 61 - 66
  • [5] La Fauci V, 2018, NEW MICROBIOL, V41, P42
  • [6] Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance
    Magiorakos, A. -P.
    Srinivasan, A.
    Carey, R. B.
    Carmeli, Y.
    Falagas, M. E.
    Giske, C. G.
    Harbarth, S.
    Hindler, J. F.
    Kahlmeter, G.
    Olsson-Liljequist, B.
    Paterson, D. L.
    Rice, L. B.
    Stelling, J.
    Struelens, M. J.
    Vatopoulos, A.
    Weber, J. T.
    Monnet, D. L.
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2012, 18 (03) : 268 - 281
  • [7] Global Spread of Carbapenemase-producing Enterobacteriaceae
    Nordmann, Patrice
    Naas, Thierry
    Poirel, Laurent
    [J]. EMERGING INFECTIOUS DISEASES, 2011, 17 (10) : 1791 - 1798
  • [8] Poulakou G, 2014, FUTURE MICROBIOL, V9, P1053, DOI [10.2217/fmb.14.58, 10.2217/FMB.14.58]
  • [9] Sabbatucci M, 2017, 1718 ISTISAN
  • [10] Squeri R, 2012, J PREV MED HYG, V53